COMING SOON!
OTC-HOPE study – a first-in-human study of an investigational gene editing therapy for infant males less than nine months of age with genetically confirmed neonatal onset OTC deficiency.
For additional information on this and other OTC deficiency clinical research studies, please visit ClinicalTrials.gov. If you are a healthcare provider and would like to learn more about this study, please email medinfo@iecure.com.
More information on this study will be coming. Check back soon.
CONTACT US
Please use this form to contact us if you would like to receive updates on the OTC-HOPE study.*
